Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking.

Nanoparticles have many potential applications in tumor therapy. Systemically administered nanoparticles should remain in circulation for a long time to increase their accumulation in targeted tissues before being cleared by the reticuloendothelial system, and be effectively internalized by the targeted cells, which can be influenced significantly by the physicochemical characteristics of nanoparticles, such as particle size, surface properties, and particle shape. This review highlights the impact of the main affects of physicochemical properties on nanoparticle transport behavior in blood, their uptake and clearance by macrophages and their consequent biodistribution, as well as their interaction with targeted cells.

[1]  R. Müller,et al.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.

[2]  H. Merkle,et al.  Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Hao Li,et al.  The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells , 2011, Nanotechnology.

[4]  M Ferrari,et al.  The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows. , 2008, Journal of biomechanics.

[5]  V. Josserand,et al.  Effect of poly(ethylene glycol) length on the in vivo behavior of coated quantum dots. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[6]  Bengt Rippe,et al.  Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. , 2005, American journal of physiology. Renal physiology.

[7]  M Ferrari,et al.  Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[8]  M. Prato,et al.  Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[10]  Chung-Yuan Mou,et al.  The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. , 2007, Biomaterials.

[11]  M. Ferrari,et al.  A Theoretical Model for the Margination of Particles within Blood Vessels , 2005, Annals of Biomedical Engineering.

[12]  Samir Mitragotri,et al.  Red blood cell-mimicking synthetic biomaterial particles , 2009, Proceedings of the National Academy of Sciences.

[13]  Shaoyi Jiang,et al.  Zwitterionic polymers exhibiting high resistance to nonspecific protein adsorption from human serum and plasma. , 2008, Biomacromolecules.

[14]  Chung-Yuan Mou,et al.  Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. , 2009, Small.

[15]  Sudipta Seal,et al.  Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. , 2007, Biomaterials.

[16]  S. Davis,et al.  Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Michel Vert,et al.  Biodistribution of Long-Circulating PEG-Grafted Nanocapsules in Mice: Effects of PEG Chain Length and Density , 2001, Pharmaceutical Research.

[18]  Stephanie E. A. Gratton,et al.  The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.

[19]  K. Landfester,et al.  Preparation of Fluorescent Carboxyl and Amino Functionalized Polystyrene Particles by Miniemulsion Polymerization as Markers for Cells , 2005 .

[20]  Samir Mitragotri,et al.  Shape Induced Inhibition of Phagocytosis of Polymer Particles , 2008, Pharmaceutical Research.

[21]  Baorui Liu,et al.  The effect of hydrophilic chain length and iRGD on drug delivery from poly(ε-caprolactone)-poly(N-vinylpyrrolidone) nanoparticles. , 2011, Biomaterials.

[22]  You Han Bae,et al.  Super pH-sensitive multifunctional polymeric micelle. , 2005, Nano letters.

[23]  P. Couvreur,et al.  Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.

[24]  R L Juliano,et al.  The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. , 1975, Biochemical and biophysical research communications.

[25]  L. Medina-Kauwe,et al.  Erratum: Chemotherapy targeting by DNA capture in viral protein particles (Nanomedicine (2012) 7:3 (335-352)) , 2012 .

[26]  K. Landfester,et al.  Criteria impacting the cellular uptake of nanoparticles: a study emphasizing polymer type and surfactant effects. , 2011, Acta biomaterialia.

[27]  A. Herrmann,et al.  Cellular Uptake of DNA Block Copolymer Micelles with Different Shapes , 2008 .

[28]  Ick Chan Kwon,et al.  Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Samir Mitragotri,et al.  Polymer particles that switch shape in response to a stimulus , 2010, Proceedings of the National Academy of Sciences.

[30]  Samir Mitragotri,et al.  Designer Biomaterials for Nanomedicine , 2009 .

[31]  Petra Krystek,et al.  Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.

[32]  R. Jain,et al.  Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Brian G. Trewyn,et al.  Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration , 2008 .

[34]  Brad A. Kairdolf,et al.  Minimizing nonspecific cellular binding of quantum dots with hydroxyl-derivatized surface coatings. , 2008, Analytical chemistry.

[35]  L. Juillerat-Jeanneret,et al.  Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells , 2012, International journal of nanomedicine.

[36]  Gert Storm,et al.  Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system , 1995 .

[37]  Cui Tang,et al.  Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.

[38]  David F. Moore,et al.  Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: What should be the policy? , 2011, NeuroImage.

[39]  F. Yuan,et al.  Transvascular drug delivery in solid tumors. , 1998, Seminars in radiation oncology.

[40]  Hamidreza Ghandehari,et al.  Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[41]  Y. Sugiyama,et al.  Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[42]  Tetsuya Osaka,et al.  Effect of surface charge of magnetite nanoparticles on their internalization into breast cancer and umbilical vein endothelial cells. , 2009, Colloids and surfaces. B, Biointerfaces.

[43]  A. Azadi,et al.  Pharmacokinetic Consequences of Pegylation , 2006, Drug delivery.

[44]  Francesco Stellacci,et al.  Effect of surface properties on nanoparticle-cell interactions. , 2010, Small.

[45]  Warren C W Chan,et al.  Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. , 2007, Nano letters.

[46]  M Ferrari,et al.  The receptor-mediated endocytosis of nonspherical particles. , 2008, Biophysical journal.

[47]  R K Jain,et al.  Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.

[48]  Zongxi Li,et al.  Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. , 2011, ACS nano.

[49]  Yuan Yuan,et al.  Long-circulation of hemoglobin-loaded polymeric nanoparticles as oxygen carriers with modulated surface charges. , 2009, International journal of pharmaceutics.

[50]  Warren C W Chan,et al.  Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.

[51]  E. Fabian,et al.  Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats , 2008, Archives of Toxicology.

[52]  V. Rotello,et al.  Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles , 2011, PloS one.

[53]  A. Zahr,et al.  Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). , 2006, Langmuir : the ACS journal of surfaces and colloids.

[54]  Hamidreza Ghandehari,et al.  Cellular uptake and cytotoxicity of silica nanotubes. , 2008, Nano letters.

[55]  Scott E McNeil,et al.  Nanomaterial standards for efficacy and toxicity assessment. , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[56]  J. DeSimone,et al.  Microfabricated Particles for Engineered Drug Therapies: Elucidation into the Mechanisms of Cellular Internalization of PRINT Particles , 2008, Pharmaceutical Research.

[57]  C. Vauthier,et al.  Complement Activation by Core–Shell Poly(isobutylcyanoacrylate)–Polysaccharide Nanoparticles: Influences of Surface Morphology, Length, and Type of Polysaccharide , 2006, Pharmaceutical Research.

[58]  D. Drubin,et al.  Functional cooperation between the microtubule and actin cytoskeletons. , 2000, Current opinion in cell biology.

[59]  T. Niidome,et al.  The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[60]  Seymour,et al.  Control of tumour vascular permeability. , 1998, Advanced drug delivery reviews.

[61]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[62]  Robert Sinclair,et al.  Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. , 2008, Small.

[63]  J. Kjems,et al.  Accumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumors. , 2012, Nanoscale.

[64]  Y. Kawashima,et al.  Polymer coating of liposomes with a modified polyvinyl alcohol and their systemic circulation and RES uptake in rats. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[65]  Chi‐Hwa Wang,et al.  Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[66]  Shaoyi Jiang,et al.  Ultralow‐Fouling, Functionalizable, and Hydrolyzable Zwitterionic Materials and Their Derivatives for Biological Applications , 2010, Advanced materials.

[67]  Kit S Lam,et al.  The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. , 2011, Biomaterials.

[68]  Yu Zhang,et al.  Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro. , 2009, Colloids and surfaces. B, Biointerfaces.

[69]  S. Luo,et al.  Surface-modified gold nanoshells for enhanced cellular uptake. , 2011, Journal of biomedical materials research. Part A.

[70]  Lisbeth Illum,et al.  Long circulating microparticulate drug carriers , 1995 .

[71]  Thomas D. Dziubla,et al.  Polymeric carriers: role of geometry in drug delivery , 2008, Expert opinion on drug delivery.

[72]  Robert N Grass,et al.  Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. , 2005, Environmental science & technology.

[73]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[74]  D. Bazile,et al.  Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. , 1995, Journal of pharmaceutical sciences.

[75]  K. Landfester,et al.  Specific effects of surface amines on polystyrene nanoparticles in their interactions with mesenchymal stem cells. , 2010, Biomacromolecules.

[76]  S. Bhatia,et al.  Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging , 2008, Advanced materials.

[77]  Jinming Gao,et al.  Modeling particle shape-dependent dynamics in nanomedicine. , 2011, Journal of nanoscience and nanotechnology.

[78]  M. Olivo,et al.  Critical parameters in the pegylation of gold nanoshells for biomedical applications: An in vitro macrophage study , 2009, Journal of drug targeting.

[79]  H. Gu,et al.  Prolonged in vivo circulation time by zwitterionic modification of magnetite nanoparticles for blood pool contrast agents. , 2012, Contrast media & molecular imaging.

[80]  Stephen M. Roberts,et al.  Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies , 2007 .

[81]  H. Kitano,et al.  Carboxybetaine polymer-protected gold nanoparticles: High dispersion stability and resistance against non-specific adsorption of proteins , 2007 .

[82]  N. Gu,et al.  Effects of Proteins from Culture Medium on Surface Property of Silanes- Functionalized Magnetic Nanoparticles , 2008, Nanoscale research letters.

[83]  Dennis E Discher,et al.  Flexible filaments for in vivo imaging and delivery: persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkage. , 2009, Molecular pharmaceutics.

[84]  Michael J Sailor,et al.  Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. , 2009, Small.

[85]  A. Rigotti,et al.  The Class B Scavenger Receptors SR-BI and CD36 Are Receptors for Anionic Phospholipids (*) , 1995, The Journal of Biological Chemistry.

[86]  S. Moghimi,et al.  PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance , 2002, FEBS letters.

[87]  Shaoyi Jiang,et al.  Novel zwitterionic-polymer-coated silica nanoparticles. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[88]  Véronique Préat,et al.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[89]  Michael J Sailor,et al.  Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. , 2009, Cancer research.

[90]  Jean-Christophe Leroux,et al.  Effect of poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles. , 2009, Biomacromolecules.

[91]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[92]  Mansoor M. Amiji,et al.  Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery , 2007, Pharmaceutical Research.

[93]  A. Rigotti,et al.  Sterol Carrier Protein-2 Is Involved in Cholesterol Transfer from the Endoplasmic Reticulum to the Plasma Membrane in Human Fibroblasts (*) , 1995, The Journal of Biological Chemistry.

[94]  P. Couvreur,et al.  Stealth® PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting , 1999 .

[95]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[96]  E. Goldys,et al.  Non-specific cellular uptake of surface-functionalized quantum dots. , 2010, Nanotechnology.

[97]  Y. Kawashima,et al.  Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[98]  Samir Mitragotri,et al.  Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[99]  S. Slack,et al.  Particle diameter influences adhesion under flow. , 2001, Biophysical journal.

[100]  Samir Mitragotri,et al.  Macrophages Recognize Size and Shape of Their Targets , 2010, PloS one.

[101]  Bruce W. Erickson,et al.  Novel Long-circulating Liposomes Containing Peptide Library-lipid Conjugates: Synthesis and In Vivo Behavior , 2004, Journal of drug targeting.

[102]  D. Fischer,et al.  Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[103]  Si-Shen Feng,et al.  Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. , 2005, Biomaterials.

[104]  Joseph D. Andrade,et al.  Protein—surface interactions in the presence of polyethylene oxide , 1991 .

[105]  S. Haupt,et al.  Drug targeting by surface cationization. , 2000, Critical reviews in therapeutic drug carrier systems.

[106]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[107]  P. Devarajan,et al.  Particle shape: a new design parameter for passive targeting in splenotropic drug delivery. , 2010, Journal of pharmaceutical sciences.

[108]  T. Ishida,et al.  Evasion of the accelerated blood clearance phenomenon by coating of nanoparticles with various hydrophilic polymers. , 2010, Biomacromolecules.

[109]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[110]  C. Miller,et al.  Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes. , 1998, Biochemistry.

[111]  Hua Yue,et al.  Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. , 2011, Biomacromolecules.

[112]  Hiroshi Maeda,et al.  Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues , 1998, Japanese journal of cancer research : Gann.

[113]  S. Yoo,et al.  Highly ordered hexagonal arrays of hybridized micelles from bimodal self-assemblies of diblock copolymer micelles. , 2010, Macromolecular rapid communications.

[114]  Zhen Cheng,et al.  Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. , 2010, ACS nano.

[115]  K. Avgoustakis,et al.  Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. , 2003, International journal of pharmaceutics.

[116]  Sven Frokjaer,et al.  Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. , 2005, International journal of pharmaceutics.

[117]  A. Torres,et al.  Exploiting cell surface thiols to enhance cellular uptake. , 2012, Trends in biotechnology.

[118]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[119]  Mina Choi,et al.  The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. , 2009, Toxicology letters.

[120]  Y. Pei,et al.  Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity. , 2006, Journal of pharmaceutical sciences.

[121]  K. Landfester,et al.  Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells. , 2008, Macromolecular bioscience.

[122]  Mauro Ferrari,et al.  Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.

[123]  H. Dai,et al.  In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. , 2020, Nature nanotechnology.

[124]  H. Ghandehari,et al.  Silica nanoconstruct cellular toleration threshold in vitro. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[125]  Samir Mitragotri,et al.  Polymer particle shape independently influences binding and internalization by macrophages. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[126]  Samir Mitragotri,et al.  Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[127]  Jean-Pierre Benoit,et al.  Parameters influencing the stealthiness of colloidal drug delivery systems. , 2006, Biomaterials.

[128]  M Ferrari,et al.  The adhesive strength of non-spherical particles mediated by specific interactions. , 2006, Biomaterials.

[129]  R Weissleder,et al.  Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. , 2000, Radiology.

[130]  J. Bacri,et al.  Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. , 2003, Biomaterials.

[131]  G. Lu,et al.  Subcellular compartment targeting of layered double hydroxide nanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[132]  H. Maeda,et al.  Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.

[133]  Vincent M. Rotello,et al.  Tuning Payload Delivery in Tumour Cylindroids using Gold Nanoparticles , 2010, Nature nanotechnology.

[134]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[135]  Wim E Hennink,et al.  Pharmacokinetics of poly(hydroxyethyl-l-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration. , 2007, Biochimica et biophysica acta.

[136]  Vladimir P Torchilin,et al.  Enhanced transfection of tumor cells in vivo using “Smart” pH-sensitive TAT-modified pegylated liposomes , 2007, Journal of drug targeting.

[137]  Dong Chen,et al.  The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. , 2010, Biomaterials.

[138]  Samir Mitragotri,et al.  Role of Particle Size in Phagocytosis of Polymeric Microspheres , 2008, Pharmaceutical Research.

[139]  Takuro Niidome,et al.  PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[140]  K. Yadav,et al.  Long circulating nanoparticles of etoposide using PLGA‐MPEG and PLGA‐pluronic block copolymers: characterization, drug‐release, blood‐clearance, and biodistribution studies , 2010 .

[141]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[142]  Jun Qian,et al.  Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles , 2005, Acta Pharmacologica Sinica.

[143]  J. Schlenoff,et al.  Zwitterion-stabilized silica nanoparticles: toward nonstick nano. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[144]  Joseph M DeSimone,et al.  Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[145]  M. Edirisinghe,et al.  Preparation of polymeric carriers for drug delivery with different shape and size using an electric jet. , 2009, Current pharmaceutical biotechnology.

[146]  Nathan Kohler,et al.  Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. , 2002, Biomaterials.

[147]  Lei Zhang,et al.  Functionalizable and ultra stable nanoparticles coated with zwitterionic poly(carboxybetaine) in undiluted blood serum. , 2009, Biomaterials.

[148]  Manuela Semmler-Behnke,et al.  Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. , 2010, Biomaterials.

[149]  Shaoyi Jiang,et al.  Functionalizable and ultra-low fouling zwitterionic surfaces via adhesive mussel mimetic linkages. , 2010, Biomaterials.

[150]  S. Hirota,et al.  Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome. , 2002, International journal of pharmaceutics.

[151]  James L. McGrath,et al.  The influence of protein adsorption on nanoparticle association with cultured endothelial cells. , 2009, Biomaterials.

[152]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[153]  Srirang Manohar,et al.  Blood clearance and tissue distribution of PEGylated and non-PEGylated gold nanorods after intravenous administration in rats. , 2011, Nanomedicine.

[154]  R. Müller,et al.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.

[155]  Simon Labrecque,et al.  Microglial response to gold nanoparticles. , 2010, ACS nano.

[156]  Y. Yoshioka,et al.  The use of PVP as a polymeric carrier to improve the plasma half-life of drugs. , 2004, Biomaterials.

[157]  W. D. de Jong,et al.  The kinetics of the tissue distribution of silver nanoparticles of different sizes. , 2010, Biomaterials.

[158]  Min Huang,et al.  Exploring the cell uptake mechanism of phospholipid and polyethylene glycol coated gold nanoparticles , 2012, Nanotechnology.

[159]  Samir Mitragotri,et al.  Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[160]  K. Landfester,et al.  Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. , 2006, Biomaterials.

[161]  Mauro Ferrari,et al.  Design of bio-mimetic particles with enhanced vascular interaction. , 2009, Journal of biomechanics.

[162]  P Couvreur,et al.  Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. , 1997, Life sciences.

[163]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[164]  R. Murthy,et al.  Opsonization, Biodistribution, Cellular Uptake and Apoptosis Study of PEGylated PBCA Nanoparticle as Potential Drug Delivery Carrier , 2011, Pharmaceutical Research.

[165]  Samir Mitragotri,et al.  Physical approaches to biomaterial design. , 2009, Nature materials.

[166]  L. Juillerat-Jeanneret,et al.  Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. , 2005, Biomaterials.

[167]  R. Lévy,et al.  PEGylation modulates the interfacial kinetics of proteases on peptide-capped gold nanoparticles. , 2009, Chemical communications.

[168]  R K Jain,et al.  Vascular permeability in a human tumour xenograft: molecular charge dependence , 2000, British Journal of Cancer.

[169]  Feng Xu,et al.  In vitro macrophage uptake and in vivo biodistribution of PLA–PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content , 2009, Journal of materials science. Materials in medicine.

[170]  Rassoul Dinarvand,et al.  PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. , 2008, International journal of pharmaceutics.

[171]  I. Zuhorn,et al.  Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.

[172]  Stephen R Pennington,et al.  Surface-induced changes in protein adsorption and implications for cellular phenotypic responses to surface interaction. , 2006, Biomaterials.

[173]  Katharina Landfester,et al.  Interaction of nanoparticles with cells. , 2009, Biomacromolecules.

[174]  Hassan S. Bazzi,et al.  Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots , 2005, Journal of Molecular Medicine.

[175]  S. Mitragotri,et al.  Endocytosis and Intracellular Distribution of PLGA Particles in Endothelial Cells: Effect of Particle Geometry. , 2010, Macromolecular rapid communications.

[176]  Keishiro Tomoda,et al.  Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.

[177]  J. Kjems,et al.  Size-Dependent Accumulation of PEGylated Silane-Coated Magnetic Iron Oxide Nanoparticles in Murine Tumors. , 2009, ACS nano.

[178]  Jia-cong Shen,et al.  Zwitterionic phosphorylcholine-protected water-soluble Ag nanoparticles , 2009 .

[179]  G Ulrich Nienhaus,et al.  Zwitterionic biocompatible quantum dots for wide pH stability and weak nonspecific binding to cells. , 2009, ACS nano.